Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI Patients

NCT00536887 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT00536887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI Patients
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2005
Completion date
September 30, 2008
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction